Our finding that mutant IDH1 ctDNA was detected in the vast majority of patients with high grade CS harboring an IDH1 mutation indicates that preoperative detection of ctDNA could potentially replace the need for a CT‐guided needle biopsy—the conventional means of obtaining a bone tumor diagnosis. This evidence concerns the gene IDH1 and bone neoplasm.